Ying Cao

Dr. Ying Cao


Research Focus & Metrics

Academic Career Length

2Years (2025-Present)

(Calculated once Scilit publication data is synced: current year − year of first publication + 1)

Representative Publications

View All Publications
23 February 2026 in Frontiers in Pharmacology
Verified
Journal Article
Open access
PDF file
LOLing Ou
Ling Ou
QDQian Du
Qian Du
JLJiayang Liu
Jiayang Liu
HTHaiyan Tai
Haiyan Tai
YCYinghan Chai
Yinghan Chai
TZTingting Zhu
Tingting Zhu
Introduction: The liver, as the central metabolic hub of the body, is highly susceptible to diet-induced injury. The increasing prevalence of metabolic dysfunction-associated steatotic liver disease (MASLD) highlights the urgent need for effective clinical interventions. Currently, there are no specific therapeutics for MASLD, and dietary patterns are closely associated with its pathogenesis, making the exploration of natural bioactive compounds a promising strategy. Methods: In this study, we identified acetylshikonin (AS), a component derived from traditional Chinese medicine (TCM), as a core bioactive agent targeting MASLD via a cross-screening strategy of MASLD-related TCM formulas. Male mouse models of MASLD were induced by a high-fat and high-cholesterol (HFHC) diet or carbon tetrachloride (CCl4) and treated with AS (600 mg/kg, gavage) for six consecutive weeks. In vitro experiments were conducted on Hepa1-6 and HCCLM3 hepatocytes stimulated with palmitic acid/oleic acid (PA/OA, 1:2). Integrated network pharmacology, molecular docking, and thermal shift assays were applied to explore the underlying mechanism. Results: In vivo results showed that AS markedly attenuated hepatic steatosis (assessed by triglyceride and total cholesterol levels) and liver fibrosis (evaluated by collagen deposition). In vitro, AS suppressed intracellular lipid accumulation (validated by Oil Red O staining and lipid quantification) and inflammatory responses (assessed by pro-inflammatory cytokine expression) in the stimulated hepatocytes. Mechanistically, AS downregulated the transcriptional expression of key genes involved in lipid metabolism (Pparγ and Srebp1c), inflammation (Tnfα and Ccl2), and fibrosis (Col1a1 and Acta2) pathways. Integrated analyses confirmed peroxisome proliferator-activated receptor γ (PPARγ) as the core direct target of AS. Western blotting demonstrated that AS reduced PPARγ protein expression, and its lipid-lowering effect was synergistically enhanced when combined with the PPARγ antagonist GW9662. Discussion: This is the first study to definitively confirm that AS exerts therapeutic effects on diet-induced MASLD by targeting the PPARγ signaling pathway, thereby reducing hepatic lipid deposition, alleviating inflammation, and ameliorating liver fibrosis progression. Our findings provide novel experimental evidence supporting the use of natural products in MASLD treatment and lay a theoretical foundation for the application of AS in the health management of diet-related liver diseases.

25 September 2025 in Medical Image Analysis
Verified
Journal Article
Closed access
BFBangkang Fu
Bangkang Fu
JHJunjie He
Junjie He
XZXiaoli Zhang
Xiaoli Zhang
YPYunsong Peng
Yunsong Peng
ZZZhuxu Zhang
Zhuxu Zhang
RWRongpin Resonance Imaging Ultrasound Fusion Guided Prostate biopsy Improves Cancer Detection Following Trans Wang
Rongpin Resonance Imaging Ultrasound Fusion Guided Prostate biopsy Improves Cancer Detection Following Trans Wang

1 September 2025 in Food Science and Human Wellness
Verified
Journal Article
Open access
PDF file
GLGuang-Yang Liu
Guang-Yang Liu
XYXian-Hui Yang
Xian-Hui Yang
JYJia Yu
Jia Yu
TZTing-Ting Zhu
Ting-Ting Zhu
YTYe Tian
Ye Tian
YCYing Cao
Ying Cao
A high-fat diet (HFD) has been implicated in the development of prostatic fibrosis, which, either independently or in combination with benign prostatic hyperplasia (BPH), can result in lower urinary tract symptoms (LUTS) in elderly men. Rosa roxburghii Tratt (RRT), a food with both edible and medicinal properties, is rich in a diverse range of bioactive compounds, including terpenoids, organic acids, polyphenols, coumarins, glycosides, amino acids, flavonoids, and phthalides. In this study, we employed an HFD-induced prostatic fibrosis mouse model to investigate the anti-fibrotic effects of RRT extracts and the underlying mechanisms. Treatment with RRT extracts mitigated the progression of prostatic fibrosis by addressing lipid metabolic dysregulation, inflammation, oxidative stress, and imbalances in sex hormone levels. Furthermore, RRT extracts reduced the incidence of bladder urine retention in HFD-fed mice and inhibited the TGF-β/Smad signaling pathway, a key mediator of fibrosis. Collectively, these findings suggest that RRT extracts may ameliorate HFD-induced prostatic fibrosis through a multi-target, multi-component approach. This study provides valuable experimental insights into the pathogenesis of HFD-induced prostatic fibrosis and supports the potential therapeutic application of RRT in health, food, and medicinal contexts.

Verified
Journal Article
Open access
PDF file
ZYZiqi Yang
Ziqi Yang
XYXianhui Yang
Xianhui Yang
JDJuan Du
Juan Du
SLShangwei Li
Shangwei Li
YJYu Jia
Yu Jia
YCYing Cao
Ying Cao
Inflammatory Bowel Disease (IBD) is a chronic, recurrent intestinal inflammatory disorder with an unclear etiology. Current pharmaceutical therapies for IBD still have several side effects, necessitating safer and more effective strategies. Edible insects are novel nutritional and bioactive resources with potential anti-inflammatory properties, but the effects of Zophobas morio larvae (ZML) and Tenebrio molitor larvae (TML) on IBD remain insufficiently explored. A 3% dextran sodium sulfate (DSS)-induced mouse colitis model was established to evaluate ZML protein powder (ZMLpp) and TML protein powder (TMLpp). Disease Activity Index (DAI), colon length, spleen weight, histopathology, inflammatory cell infiltration (LCA/MPO staining), inflammatory cytokines (Ccl2, Cxcl1, Ptgs2, Nf-κb), and intestinal microbiota (16S rRNA sequencing) were determined. The result showed that compared with the DSS group, both ZMLpp and TMLpp significantly reduced DAI, mitigated weight loss and hematochezia/diarrhea, restored colon length, attenuated mucosal damage, and preserved goblet cells and crypts, inflammatory cell infiltration, downregulated cytokine expression, improved fecal microbiota dysbiosis, such as increased abundance of beneficial bacteria like Akkermansia. These findings demonstrate that both ZMLpp and TMLpp alleviate DSS-induced colitis by inhibiting inflammation and modulating the microbiota, supporting their application in IBD therapy and the development of anti-colitis functional foods or pharmaceuticals.

5 May 2025 in Medical Oncology
Verified
Journal Article
Closed access
PDF file
RWRui Wang
Rui Wang
XYXingsheng Yao
Xingsheng Yao
JYJia Yu
Jia Yu
XWXinwei Wan
Xinwei Wan
SLShengyou Li
Shengyou Li
HLHeng Luo
Heng Luo

4 September 2026 in Neuropeptides
Verified
Journal Article
Closed access
DXDexin Xiong
Dexin Xiong
ZWZhixian Wan
Zhixian Wan
LHLinfei Hu
Linfei Hu
YLYuhan Luo
Yuhan Luo
YTYing Tan
Ying Tan
JZJiqin Zhang
Jiqin Zhang